FDA Approves Mesalamine Delayed–Release Tablets, Generic of Lialda, for UC

FDA Approves Mesalamine Delayed–Release Tablets, Generic of Lialda, for UC

The U.S. Food and Drug Administration (FDA) has given final approval for Zydus Cadila to market Mesalamine Delayed–Release Tablets USP, a generic version of Lialda, in the U.S. to treat ulcerative colitis (UC).

The announcement follows news in May that Zydus had won a court battle over Shire’s patent for Lialda. The U.S. Court of Appeals for the Federal Circuit ruled that Zydus’ proposed generic version of Lialda does not infringe upon Shire’s patent covering the drug.

Zydus, owned by India’s Cadila Healthcare, was the first company that questioned Shire’s rights to Lialda by filing an abbreviated new drug application with the FDA for a generic version of Lialda in 2010, according to reporting by Law360.

Mesalamine is a compound that has been around for years and is not patent protected. Shire’s patent covers the release mechanism, allowing the drug to travel through the intestines untouched until it reaches the colon. U.S. Patent No. 6,773,720 protects this delayed-release mechanism.

Lialda, developed and commercialized by Shire, is currently approved for the induction of remission in patients with active mild-to-moderate ulcerative colitis. It can also be used for the maintenance of remission. The recommended dosage for the induction of remission in adult patients with active mild to moderate UC is two to four 1.2–gram tablets taken once daily with a meal for a total daily dose of 2.4 grams or 4.8 grams.

The recommended dosage for the maintenance of remission is two 1.2–gram tablets taken once daily with a meal for a total daily dose of 2.4 grams.

According to Zydus estimates, brand sales for Mesalamine Delayed-Release Tablets USP, 1.2 grams, could be as high as $1.1 billion. The generic version of Lialda will be produced at the Moraiya plant in Ahmedabad, India.

UC is an inflammatory bowel disease (IBD) that causes long–lasting inflammation and ulcers in the digestive tract. The disease affects the innermost lining of the large intestine and rectum. Symptoms usually develop over time rather than suddenly. UC can be debilitating and lead to life–threatening complications. While currently there is no cure, treatment can reduce signs and symptoms of the disease.


    • Not a happy camper says:

      Lialda also offered discounts each year… $500 off each month for the first 3 months and $120 off each month after that for the remainder of the year. I only take 2 tablets a day so my cost was $10 a month but now my insurance company won’t cover name brand as long as a generic is available. So lucky me I get to pay $455.02 a month for Zydus.

      • Pam S. says:

        My insurance company said have doctor write a prescription for “Lialda brand only”. Also they said after 6 months generic may get cheaper, keep checking prices.

    • AL Franks says:

      It would be wonderful news if Zydus offered manufacture discount cards like Lialda does. I will be pauing full price now for Zydus until I meet my insurance deductible of $2800, because insurance company won’t cover name brand as long as there is a generic. The price is $561.02 for Lialda and $445.25 for Zydus for one month 60 tables. Lialda discounts are $500 a month for the first 3 months and $120 a month for the rest of the year. So this is not good news for many people.

  1. Bob says:

    What a BAG O Bull $hiT. Finally a Generic for Lialda and it’s just VERY moderately less expensive. Went through this same CRAP with Asacol. Time for the patent to run out and they change the pill cover and low and behold, patent renewed. Change to Lialda then the same ole same ole. Congratulations to those who once again screw the sick. Time to put some kind of price control on these money hungry/grubbing bastards. Profit, sure. Billions in sales off of the sick and tens of millions for the CEO’s whose only wise way of running these companies is, “Raise the prices”. WOW.

  2. Pam S. says:

    I was just notified Lialda Savings cards are discontinued as of October 15. I doubt they will offer them again in 2018 but I will check in January.

Leave a Comment

Your email address will not be published. Required fields are marked *